- Home
- TD vs SYK Comparison
TD vs SYK Comparison
Compare TD & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TD
- SYK
- Stock Information
- Founded
- TD 1855
- SYK 1941
- Country
- TD Canada
- SYK United States
- Employees
- TD N/A
- SYK 53000
- Industry
- TD
- SYK Medical/Dental Instruments
- Sector
- TD
- SYK Health Care
- Exchange
- TD Nasdaq
- SYK Nasdaq
- Market Cap
- TD 126.6B
- SYK 144.9B
- IPO Year
- TD N/A
- SYK N/A
- Fundamental
- Price
- TD $74.51
- SYK $378.47
- Analyst Decision
- TD Buy
- SYK Buy
- Analyst Count
- TD 2
- SYK 19
- Target Price
- TD $91.50
- SYK $427.67
- AVG Volume (30 Days)
- TD 1.8M
- SYK 1.3M
- Earning Date
- TD 08-28-2025
- SYK 07-31-2025
- Dividend Yield
- TD 4.00%
- SYK 0.89%
- EPS Growth
- TD 63.11
- SYK N/A
- EPS
- TD 6.97
- SYK 7.55
- Revenue
- TD $45,024,677,580.00
- SYK $23,818,000,000.00
- Revenue This Year
- TD $10.95
- SYK $10.75
- Revenue Next Year
- TD $3.82
- SYK $8.35
- P/E Ratio
- TD $10.69
- SYK $50.19
- Revenue Growth
- TD 20.69
- SYK 11.36
- 52 Week Low
- TD $51.25
- SYK $328.24
- 52 Week High
- TD $75.58
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- TD 59.48
- SYK 41.38
- Support Level
- TD $72.72
- SYK $373.72
- Resistance Level
- TD $73.80
- SYK $381.34
- Average True Range (ATR)
- TD 0.78
- SYK 5.85
- MACD
- TD -0.03
- SYK -1.41
- Stochastic Oscillator
- TD 90.71
- SYK 19.33
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 55% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 40% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.